Trial Profile
A Study To Determine The Safety And Tolerability Of Long Term Use Of Tedizolidin In Patients With Nontuberculous Mycobacterial Infections.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Dec 2016
Price :
$35
*
At a glance
- Drugs Tedizolid (Primary)
- Indications Nontuberculous mycobacterium infections
- Focus Adverse reactions
- 31 Dec 2016 New trial record